Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion

MeSH terms

• Aged
• Alendronate / therapeutic use
• Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology*
• Bone Density Conservation Agents / administration & dosage*
• Bone Density Conservation Agents / adverse effects
• Bone Density Conservation Agents / therapeutic use
• Bone Diseases, Metabolic / drug therapy
• Diphosphonates / administration & dosage*
• Diphosphonates / adverse effects
• Diphosphonates / therapeutic use
• Etidronic Acid / analogs & derivatives
• Etidronic Acid / therapeutic use
• Female
• Follow-Up Studies
• Humans
• Ibandronic Acid
• Imidazoles / administration & dosage*
• Imidazoles / adverse effects
• Infusions, Intravenous
• Mandibular Diseases / chemically induced*
• Maxillary Diseases / chemically induced*
• Middle Aged
• Osteoporosis, Postmenopausal / drug therapy*
• Risedronic Acid
• Tooth Extraction / adverse effects
• Tooth Socket / pathology
• Zoledronic Acid